The Efficacy of Neo-Biphyllin Retard in Asthmatic Patients--a Theophylline Slow-releasing Coated Tablet

Overview

Journal Pneumonologie

Specialty Pulmonary Medicine

Date 1976 Jun 25

PMID 785410

Authors

H Albrecht

C Messerli

M Scherrer

Affiliations

Soon will be listed here.

References

BATTIG K . [Acute and semi-chronic toxicity of various xanthine combinations]. Arzneimittelforschung. 1971; 21(3):354-6. View

TIVENIUS L . Comparison of drugs for asthma. Br Med J. 1971; 2(5764):773. PMC: 1796370. DOI: 10.1136/bmj.2.5764.773-b. View

Jenne J, Wyze M, Rood F, Macdonald F . Pharmacokinetics of theophylline. Application to adjustment of the clinical dose of aminophylline. Clin Pharmacol Ther. 1972; 13(3):349-60. DOI: 10.1002/cpt1972133349. View

Tomita Y, Patterson R, SUSZKO I . Respiratory mast cells and basophiloid cells. II. Effect of pharmocologic agents on 3'5'-adenosine monophosphate content and on antigen-induced histamine release. Int Arch Allergy Appl Immunol. 1974; 47(2):261-72. View

. Editorial: Intravenous aminophylline. Lancet. 1973; 2(7835):950. View

LEVINE E . An effective oral medication for long term bronchodilation. Ann Allergy. 1965; 23(9):403-13. View

Hudson L, Tyler M, Petty T . Oral aminophylline and dikydroxypropyl theophylline in reversible obstructive airway disease: a single-dose, double-blind, crossover comparison. Curr Ther Res Clin Exp. 1973; 15(7):367-72. View

Poisner A . Direct stimulant effect of aminophylline on catecholamine release from the adrenal medulla. Biochem Pharmacol. 1973; 22(4):469-76. DOI: 10.1016/0006-2952(73)90288-8. View

Boroda C, Miller R, Leslie S, Nicol E, Thomson I . Comparison of the bioavailability of aminophylline in a conventional base and in a continous-release base. J Clin Pharmacol. 1973; 13(10):383-7. DOI: 10.1002/j.1552-4604.1973.tb00183.x. View

10.

Lode H, HUTTEMANN U, Huckauf H . [The effect of oral by administered theophylline on specific airway resistance in airway obstruction]. Arzneimittelforschung. 1972; 22(10):1788-91. View

11.

Scherrer M, Bachofen H . [Advantages of salbutamol-tacholiquine inhalation over orciprenaline-tacholiquine inhalation in bronchial asthma]. Schweiz Med Wochenschr. 1972; 102(52):1911-4. View

12.

Bertelli A, Bianchi C, Beani L . Interaction between -adrenergic stimulant and phosphodiesterase inhibiting drugs on the bronchial muscle. Experientia. 1973; 29(3):300-2. DOI: 10.1007/BF01926489. View

13.

Mitenko P, OGILVIE R . Pharmacokinetics of intravenous theophylline. Clin Pharmacol Ther. 1973; 14(4):509-13. DOI: 10.1002/cpt1973144part1509. View

14.

Jackson R, McHENRY J, Moreland F, RAYMER W, ETTER R . CLINICAL EVALUATION OF ELIXOPHYLLIN WITH CORRELATION OF PULMONARY FUNCTION STUDIES AND THEOPHYLLINE SERUM LEVELS IN ACUTE AND CHRONIC ASTHMATIC PATIENTS. Dis Chest. 1964; 45:75-85. DOI: 10.1378/chest.45.1.75. View

15.

Nicholson D, Chick T . A re-evaluation of parenteral aminophylline. Am Rev Respir Dis. 1973; 108(2):241-7. DOI: 10.1164/arrd.1973.108.2.241. View

16.

Piafsky K, OGILVIE R . Dosage of theophylline in bronchial asthma. N Engl J Med. 1975; 292(23):1218-22. DOI: 10.1056/NEJM197506052922305. View

17.

Mitenko P, OGILVIE R . Bioavailability and efficacy of a sustained-release theophylline tablet. Clin Pharmacol Ther. 1974; 16(4):720-6. DOI: 10.1002/cpt1974164720. View